Semler Scientific, Inc. SMLR

Set alert

Price alert · SMLR

All alert types
20.33 USD 0.00 0.00%

At close · Jan 16

20.98 +0.65 +3.20%

After hours · Jan 16, 4:00 PM ET

Bid
20.34 × 8
Ask
20.36 × 1
20.33 Day range 20.33
20.88 52-week range 81.56
YTD
+32.96%
1 year
-68.69%
Open
20.33
Prev close
20.33
Mkt cap
571.43M
Vol
1.62M
Avg vol
610.88K
EPS
2.04
P/E
30.23
Div yield
0.00%
More statistics
Low
20.33
High
20.33
Forward P/E
18.30
Beta
0.92
Short ratio
1.35
Inst. own
43.48%
Dividend
0.00
Ex-div date
50-d avg
47.31
200-d avg
33.35
1y target
40.00

6M chart

Chart tools
Interval

Signals (33)
NameDateAgo
SMA: BullishJan 16, 20269 months ago
SMA: BearishJan 15, 20269 months ago
SMA: BullishJan 14, 20269 months ago
SMA: BearishJan 13, 20269 months ago
SMA: BullishJan 12, 20269 months ago
SMA: BearishJan 7, 20269 months ago
SMA: BullishJan 6, 202610 months ago
MACD: Buy SignalJan 2, 202610 months ago
MACD: Sell SignalDec 30, 202510 months ago
MACD: Buy SignalDec 24, 202510 months ago
MACD: Sell SignalDec 23, 202510 months ago
MACD: Buy SignalDec 22, 202510 months ago
MACD: Sell SignalDec 15, 202510 months ago
MACD: Buy SignalDec 3, 202511 months ago
MACD: Sell SignalNov 14, 202511 months ago
SMA: BearishNov 11, 202511 months ago
SMA: BullishNov 10, 202511 months ago
SMA: BearishNov 6, 202512 months ago
SMA: BullishNov 5, 202512 months ago
SMA: BearishOct 28, 20251 year ago

Newest 20 of 33.

Key statistics

Market cap
571.43M
Enterprise value
436.33M
Trailing P/E
30.23
Forward P/E
18.30
PEG ratio
0.00
Price / sales
9.70
Price / book
5.14
EPS (TTM)
2.04
Beta
0.92
Dividend yield
0.00%
Payout ratio
0.00%
Profit margin
27.00%
Revenue (TTM)
58.94M
Revenue growth
-17.20%
Free cash flow
-56.74M
Total cash
12.67M
Total debt
93.00K
Return on equity
20.39%
Shares outstanding
9.27M
Short % of float
18.97%
50-day average
47.31
200-day average
33.35

Financials — quick view

All financials
SMLR Revenue — quarterly 7.49M
2021-Q4 20212022-Q1 20222022-Q2 20222022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 2025
SMLR Net income — quarterly 16.90M
2021-Q4 20212022-Q1 20222022-Q2 20222022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 2025
SMLR EPS — quarterly 1.14
2021-Q4 20212022-Q1 20222022-Q2 20222022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 2025

Earnings

SMLR recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
Nov 4, 2024Sep 1, 20240.000.72——
Aug 5, 2024Jun 1, 20240.000.00——
May 7, 2024Mar 1, 20240.000.78——
Mar 5, 2024Dec 1, 20230.000.55——
Nov 9, 2023Sep 1, 20230.000.71——
Aug 10, 2023Jun 1, 20230.000.75——

Upgrades / downgrades

SMLR analyst upgrades and downgrades
DateFirmActionFromTo
Nov 2, 2022B. Riley SecuritiesdownBuyNeutral
May 3, 2022B. Riley Securitiesmain—Buy
Mar 7, 2022B. Riley Securitiesmain—Buy
Nov 2, 2021B. Riley Securitiesmain—Buy
Oct 26, 2021B. Riley Securitiesmain—Buy
May 4, 2021B. Riley Securitiesmain—Buy

About Semler Scientific, Inc.

Semler Scientific, Inc. provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company's products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition. It also offers Insulin Insights, a software program that is used by a healthcare provider to optimize outpatient insulin dosing. The company's products serve cardiologists, internists, nephrologists, endocrinologists, podiatrists, family practitioners, healthcare insurance plans, integrated delivery networks, independent physician groups, and companies contracting with the healthcare industry, such as risk assessment groups and retailers. It offers its products through sales representatives and distributors. The company was incorporated in 2007 and is headquartered in Santa Clara, California.

Sector
Healthcare
Industry
Medical Devices
Country
United States

News

Your note

Sign in to keep a note on SMLR — it syncs with the Stock Master app.

Insider holders

SMLR insider holders
InsiderRelationLatest transactionDateShares held
LEIBOWITZ ARTHUR NDirectorStock Award(Grant)Jan 31, 20234,865
MESSINA DANIEL SDirectorStock Award(Grant)Nov 6, 202411,910
MOON CINDYDirectorStock Award(Grant)Jan 31, 20233,211
MURPHY-CHUTORIAN DOUGLASChief Executive OfficerStock GiftDec 11, 2024155,313
PAN WAYNE TDirectorStock Award(Grant)Jan 31, 202347,554
SEMLER ERICDirectorConversion of Exercise of derivative securityDec 15, 2024707,367

Institution ownership

SMLR institution ownership
Holder% heldSharesValueReported
Cerity Partners LLC19.92%1,345,58682.97MSep 29, 2024
Blackrock Inc.5.43%366,56422.60MSep 29, 2024
Vanguard Group Inc4.61%311,62419.21MSep 29, 2024
Dimensional Fund Advisors LP2.74%185,28211.42MSep 29, 2024
ShariaPortfolio, Inc.2.27%153,6169.47MSep 29, 2024
Geode Capital Management, LLC2.01%135,9598.38MSep 29, 2024

Fund ownership

SMLR fund ownership
Holder% heldSharesValueReported
Vanguard Total Stock Market Index Fund2.69%181,35111.18MSep 29, 2024
iShares Russell 2000 ETF1.78%119,9887.40MOct 30, 2024
Vanguard Extended Market Index Fund1.17%79,0344.87MSep 29, 2024
Fidelity Small Cap Index Fund0.73%49,2993.04MAug 30, 2024
iShares Russell 2000 Growth ETF0.66%44,6792.75MOct 30, 2024
Fidelity Extended Market Index Fund0.47%31,9401.97MOct 30, 2024